AMH Levels and PCOS: What Your Results Mean by Age
By Dr. Fiona McCulloch, ND, author of 8 Steps to Reverse Your PCOS and peer reviewer of the 2023 International Evidence-Based Guideline for PCOS.
An elevated AMH (anti-Müllerian hormone) level is one of the most useful markers for identifying PCOS, particularly in women who have gone years without a clear diagnosis. In our Toronto PCOS clinic, I have seen many women whose AMH results were the piece that finally brought their clinical picture into focus. On this page, you will find age-specific AMH ranges in both ng/mL and pmol/L, guidance on interpreting your results for PCOS, and what to do if your number falls in the borderline zone.
When Your AMH Is Elevated, and No One Has Explained Why
You received your AMH result, and the number is higher than expected. Maybe your doctor mentioned it in passing, or maybe you found it on a lab report and started searching. Either way, you are now trying to answer a question that the test result alone does not answer: does this mean I have PCOS?
This is a common experience. Many women, especially those over 35, are told their ultrasound looks normal, their blood work is within range, and there is nothing to worry about. Yet they have irregular cycles, unexplained skin changes, or other signs that something is not quite right. Polycystic ovaries become difficult to see on ultrasound as women get older, but AMH often remains elevated, which means the standard assessment can miss what AMH reveals.
How AMH Is Used in PCOS Diagnosis
AMH is secreted by the follicles which house the eggs in our ovaries. In women with PCOS, there are typically more small antral follicles than usual, and research shows that each of these follicles also overproduces AMH individually. The combined effect is a significantly elevated AMH level.
This elevated AMH is not just a marker: it may be part of the problem. AMH works by reducing the ovary’s sensitivity to FSH, the pituitary hormone that triggers egg development each cycle. When AMH is much too high, this effect can go too far, stalling follicle development and preventing ovulation. AMH levels also correlate directly with testosterone levels, connecting ovarian function to the androgen-related symptoms many women with PCOS experience.
In 2023, the International Evidence-Based Guideline for the Assessment and Management of PCOS formally added AMH as an alternative to ultrasound for meeting the polycystic ovary morphology criterion. This was a significant change. For years, AMH had been used clinically by practitioners who recognized its diagnostic value, and I had already been using AMH as a practical replacement for the ultrasound criterion, since it reflects the ovary’s hormonal imbalance that causes ovulation to stall. The 2023 guidelines validated this approach internationally.
Under the updated Rotterdam criteria, PCOS is identified when at least 2 of the following 3 are present:
- Irregular or absent ovulation: long cycles, far-apart periods, or absent periods
- Clinical or lab signs of elevated androgens: such as hirsutism, adult acne, or androgen excess on blood work
- Polycystic ovaries on ultrasound or elevated AMH: the 2023 update now accepts AMH as an alternative to the ultrasound finding
One important nuance: AMH is less discriminating in younger women, because all younger women tend to have naturally higher AMH. It becomes more diagnostically useful in women over 35, where ultrasound frequently fails to show polycystic ovaries even when they are present. If you are younger and your AMH is elevated, the other criteria, cycle patterns and androgen signs, become especially important for interpretation.
PCOS AMH Levels by Age: Ranges in ng/mL and pmol/L
| Age | ng/ml | pmol/L |
|---|---|---|
| Under 33 years old | 2.1 - 6.8 | 15.0 - 48 |
| 33 - 37 years old | 1.7 - 3.5 | 12.14 - 32.13 |
| 38 - 40 years old | 1.1 - 3.0 | 7.8 - 21.42 |
| 41+ years old | 0.5 - 2.5 | 3.57 - 17.85 |
At Any Age: The Key Thresholds
At any age, an AMH over 6.8 ng/mL (48 pmol/L) is considered elevated and suspicious of PCOS. At very high levels, the association becomes even stronger: studies have found that around 97% of women with an AMH over 10 ng/mL (71 pmol/L) have PCOS. Values in the 4.5–7.8 ng/mL range may also be significant depending on age and other clinical findings.
Age Changes What Your Number Means
AMH levels naturally decline with age, so the same number means different things at different ages. An AMH of 6.8 in a 32-year-old may be more clinically significant than the same number in a 20-year-old, because the under-33 bracket spans a very wide age range. Over 35, AMH becomes especially valuable: it is quite rare to see polycystic ovaries on ultrasound at this age, yet AMH often remains elevated, catching what the ultrasound may miss. Some women over 35 and 40 still have very high AMH levels.
These Ranges Are Not Hard Cutoffs
These ranges are guidelines, not definitive answers. Each woman will be different depending on her whole hormonal picture. An AMH slightly above the range for your age, combined with irregular cycles and signs of androgen excess, is more significant than a number alone. Equally, an AMH that appears elevated but is accompanied by regular ovulation and no other PCOS signs may simply reflect good ovarian reserve.
If your AMH is below the range for your age and you are concerned about ovarian reserve, see our page on what to do if your AMH is low.
Not sure what your AMH level means for your situation? Our PCOS-focused naturopathic team can help interpret your results in the context of your full hormonal picture.
What If Your AMH Is Borderline?
Many women find themselves in a gray zone: their AMH is elevated for their age but not dramatically high. This borderline result can feel like a non-answer: not clearly pointing to PCOS, but not clearly ruling it out either. If this is where you are, you are not overreacting. A borderline AMH is not uncommon in women who turn out to have PCOS, and it is a clinically meaningful finding that warrants further investigation.
PCOS is not defined by a single blood test. When AMH is borderline, a clinician familiar with PCOS would assess the full clinical picture, looking for other signs that, taken together, build a clearer picture. Most women with PCOS have a mixture of different factors, and identifying which are present in each individual is what guides the path forward.
If your AMH is borderline, consider discussing these with your provider:
- Cycle length and regularity: Are your periods consistently far apart, unpredictable, or absent?
- Signs of androgen excess: Adult acne, increased facial or body hair, or thinning hair at the crown or temples
- Insulin resistance indicators: Weight gain around the midsection, skin tags, darkened skin patches, or fatigue after meals
- Family history: PCOS, type 2 diabetes, or metabolic conditions in your family
- Prior hormone testing: Any previous bloodwork results that may provide additional context
For a fuller overview of what to look for, see 14 signs you might have PCOS.
What to Expect: A PCOS Assessment at White Lotus Clinic
When a patient comes to the clinic with elevated AMH results, the assessment goes well beyond confirming or ruling out PCOS. The first visit is a 90-minute comprehensive consultation that begins with a detailed clinical interview, covering your full hormonal history, cycle patterns, symptoms, and overall health, before any tests are ordered. Because even when AMH is elevated, other PCOS-related factors may also be present and need to be individually identified.
The assessment typically evaluates:
- Metabolic markers: insulin resistance, blood sugar patterns, and liver function
- Hormones: testosterone, DHEA, FSH/LH ratio, and thyroid function
- Clinical signs: androgen excess, insulin resistance indicators, and cycle regularity
- Overall health picture: sleep, stress, nutrition, and relevant family history
The goal is to understand which PCOS factors are present in your specific case and develop an approach tailored to your individual picture. You can learn more about our approach to personalized PCOS care at our Toronto clinic.
Available in-person at our Toronto clinic or virtually across Ontario.
Frequently Asked Questions About AMH and PCOS
What AMH level indicates PCOS?
At any age, an AMH above 6.8 ng/mL (48 pmol/L) is considered elevated and may indicate PCOS. The association is particularly strong at higher levels: research has found that approximately 97% of women with an AMH over 10 ng/mL (71 pmol/L) have PCOS. However, AMH is one of three diagnostic criteria under the Rotterdam framework. An elevated AMH alone does not confirm PCOS; the 2023 guidelines require at least 2 of 3 criteria to be present.
What if my AMH is borderline, not clearly elevated?
A borderline AMH is not uncommon in women with PCOS. When the number is elevated but not dramatically high, the clinical approach is to look at the full picture: cycle regularity, signs of androgen excess, metabolic markers, and family history. A borderline result combined with irregular cycles or other PCOS signs may be clinically significant. On its own, it may simply indicate good ovarian reserve. Either way, it is a prompt for further assessment, not a dismissal.
Can AMH replace ultrasound for PCOS diagnosis?
Yes. The 2023 International Evidence-Based Guideline for PCOS formally added AMH as an alternative to ultrasound for the polycystic ovary morphology criterion. This is especially relevant for women over 35, where polycystic ovaries are less frequently visible on ultrasound even when PCOS is present. AMH often remains elevated in this group, making it a valuable diagnostic tool when ultrasound findings are inconclusive.
Does AMH go down with PCOS treatment? Does that mean I am losing eggs?
AMH may decline with effective PCOS management, but this does not mean you are losing eggs. Women with PCOS typically have a higher number of small antral follicles, some of which are dysfunctional, stalled in early development and not progressing to ovulation. These dysfunctional follicles contribute to elevated AMH. When treatment helps clear them, it is not reducing your total follicle count. It is improving follicle selection, allowing healthier follicles to develop and ovulation to become more regular. Women with PCOS will always tend to have higher AMH than average; a decline with treatment reflects the clearing of the dysfunctional portion.
Can I get an AMH test in Ontario?
Yes. AMH is a simple blood test that can be done on any day of your menstrual cycle; there is no need to time it with a specific cycle day, unlike some other hormone tests. In Ontario, your family doctor or naturopathic doctor can order the test.
I already have a family doctor. Do I need a naturopath for PCOS?
Naturopathic PCOS assessment is designed to complement, not replace, the care you receive from your family doctor. The difference is often in the scope and depth of assessment. A PCOS-focused naturopathic evaluation looks at the full metabolic and hormonal picture simultaneously: insulin resistance, androgen levels, thyroid function, inflammation markers, and cycle patterns, often using functional ranges that may reveal patterns standard reference ranges miss. Many patients come to the clinic after being told their bloodwork is “normal” but still experiencing symptoms.
What happens at a first appointment?
The first appointment is a 90-minute comprehensive assessment. It begins with a detailed clinical interview covering your full health history, cycle patterns, and symptoms. Based on the clinical picture, targeted hormone and metabolic testing is ordered. From those results, an individualized plan is developed. Appointments are available in-person at our Toronto clinic or virtually across Ontario.
Is AMH less reliable for diagnosing PCOS in younger women?
AMH is not unreliable in younger women, but it is less discriminating: all younger women tend to have naturally higher AMH levels, which makes it harder to distinguish a normal result from one that suggests PCOS. AMH becomes more diagnostically useful over 35, where ultrasound frequently fails to detect polycystic ovaries while AMH remains elevated. For women under 30 with elevated AMH, the clinical picture (cycle patterns, androgen signs, and metabolic markers) becomes even more important for accurate interpretation.
Meet the Author and Our Medical Director, Dr FIona McCulloch, ND
Dr. Fiona McCulloch, ND is the founder of White Lotus Clinic and the author of 8 Steps to Reverse Your PCOS. She served as a peer reviewer for the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome, the guideline that formally added AMH as a PCOS diagnostic criterion. A board member of the Endocrinology Association of Naturopathic Physicians (EndoANP), Dr. McCulloch has focused her clinical practice on PCOS and hormonal health for approximately 25 years.
An AMH number on its own tells you something, but interpreting it in the context of your age, hormonal picture, and overall health is what moves you from uncertainty to clarity. At White Lotus Clinic, that is the assessment we focus on: understanding which PCOS factors are present in your specific case and developing an approach that addresses them. If your AMH results have raised questions, a consultation at our Toronto PCOS clinic is a good next step.
Available in-person in Toronto or virtually across Ontario.
References
- Gleicher N, Weghofer A, Barad DH. Center for Human Reproduction. Anti-Müllerian Hormone (AMH) and Follicle Stimulating Hormone (FSH): Age Specific Baseline Ranges.
- Bhide P, Dilgil M, Gudi A, Shah A, Akwaa C, Homburg R. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study. Fertil Steril. 2015 Feb;103(2):537-41.
- Eilertsen TB, Vanky E, Carlsen SM. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Hum Reprod. 2012 Aug;27(8):2494-502.
- Yoo JH, Kim HO, Cha SW, et al. Age specific serum anti-Müllerian hormone levels in 1,298 Korean women with regular menstruation. Clinical and Experimental Reproductive Medicine. 2011;38(2):93-97.
- Teede HJ, Misso ML, Costello MF, et al. International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. 2023.